MedTech Syndicate
Overview
MedTech Syndicate is an Irish-based group of investors committed to advancing innovation in the Medical Technology sector. Founded in 2014 by experienced entrepreneurs and former leaders from renowned medtech companies such as Medtronic, Boston Scientific, Abbott, and Creganna, the syndicate brings together a wealth of experience and industry insight. Members possess diverse expertise spanning life sciences, technology, and financial services, with a network that extends internationally, enabling valuable connections worldwide. Specializing in investing in medical devices, hardware, and diagnostic technologies, MedTech Syndicate operates as an angel syndicate, providing critical funding and strategic support from the seed stage through to successful exits. This approach empowers early-stage companies to achieve their full potential. In 2024, the syndicate announced a record-breaking €10 million investment into nine companies, highlighting its significant role in fostering medtech innovation in Ireland and beyond. The syndicate's growth reflects the increasing demand for structured angel investment groups, a key pillar of Ireland's startup economy. By supporting early-stage startups, MedTech Syndicate helps fuel the development of groundbreaking technologies that can revolutionize patient care, diagnostics, and treatments worldwide. In addition to financial backing, members contribute their expertise, networks, and industry knowledge to support the growth and success of portfolio companies. This unique combination of funding and mentorship is central to the syndicate's ethos and a critical driver of its success.
Investment Focus
- Active participation in syndicate meetings
- Commitment to supporting portfolio companies
- Adherence to syndicate's investment criteria
- Compliance with legal and regulatory requirements
- Alignment with syndicate's mission and values
- Willingness to collaborate with other investors
- Ability to provide strategic guidance to startups
- Interest in the medical technology sector
- Financial capacity to invest in early-stage companies
- Understanding of investment risks and potential returns
Portfolio Companies
Get the full list of 54,000+ investors
MedTech Syndicate and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about MedTech Syndicate
What sectors does MedTech Syndicate invest in?
MedTech Syndicate invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Dublin, Ireland. MedTech Syndicate is listed as a syndicate in the ConnectSafely investor database.
What stage does MedTech Syndicate invest at?
MedTech Syndicate backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 100K - 5M.
Which regions does MedTech Syndicate invest in?
MedTech Syndicate invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at MedTech Syndicate?
Team members listed for MedTech Syndicate include Yvan Gouttebelle (Syndicate Chair) and Pat Coakley (Director).
What companies has MedTech Syndicate invested in?
MedTech Syndicate's portfolio includes CureMetrix, Bluedrop Medical, Boston Scientific, Medtronic, Ostoform, Signum Surgical, Illumicell AI and Proverum Medical.
How do I contact MedTech Syndicate?
MedTech Syndicate's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
